title: [Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
authors.forename: M
authors.initials: M
authors.lastname: Burnier
authors.forename: P-Y
authors.initials: PY
authors.lastname: Martin
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D002216:Captopril / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D016503:Drug Delivery Systems / Q000379:methods; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology; D012084:Renin-Angiotensin System / Q000187:drug effects*; D018570:Risk Assessment
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004338:Drug Combinations; D002216:Captopril